Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Catalyst Pharmaceuticals Inc..
Catalyst Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Catalyst Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Catalyst Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Catalyst Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Catalyst Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Catalyst Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Catalyst Pharmaceuticals Inc.- Key Facts
2.2 Catalyst Pharmaceuticals Inc.- Geographic Locations
2.3 Catalyst Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Catalyst Pharmaceuticals Inc.- Business Divisions
2.5 Catalyst Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Catalyst Pharmaceuticals Inc. Strategic Analysis Review
3.1 Catalyst Pharmaceuticals Inc.- Key Strategies
3.2 Catalyst Pharmaceuticals Inc.- Company Outlook Statement
3.3 Catalyst Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Catalyst Pharmaceuticals Inc.- Key Strengths
3.3.2 Catalyst Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Catalyst Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Catalyst Pharmaceuticals Inc.- Potential Threats
3.4 Catalyst Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Catalyst Pharmaceuticals Inc.- Business Overview
4.2 Catalyst Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Catalyst Pharmaceuticals Inc.- Key Products
5.2 Catalyst Pharmaceuticals Inc.- Key Service Areas
5.3 Catalyst Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Catalyst Pharmaceuticals Inc.- Company History
6.2 Catalyst Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Catalyst Pharmaceuticals Inc.- Income Statements
7.2 Catalyst Pharmaceuticals Inc.- Balance Sheet
7.3 Catalyst Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Catalyst Pharmaceuticals Inc.- Direct Competitors
8.2 Catalyst Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Catalyst Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Catalyst Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!